ChoA Pharmaceutical Co., LTD. (KOSDAQ: 034940)
South Korea
· Delayed Price · Currency is KRW
1,009.00
-31.00 (-2.98%)
Jan 22, 2025, 3:00 PM KST
ChoA Pharmaceutical Co., LTD. Revenue
ChoA Pharmaceutical Co., LTD. had revenue of 15.24B KRW in the quarter ending September 30, 2024, with 2.90% growth. This brings the company's revenue in the last twelve months to 61.46B, down -7.70% year-over-year. In the year 2023, ChoA Pharmaceutical Co., LTD. had annual revenue of 62.97B, down -8.57%.
Revenue (ttm)
61.46B
Revenue Growth
-7.70%
P/S Ratio
0.51
Revenue / Employee
245.84M
Employees
250
Market Cap
31.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 62.97B | -5.91B | -8.57% |
Dec 31, 2022 | 68.88B | 11.32B | 19.66% |
Dec 31, 2021 | 57.56B | -7.80B | -11.93% |
Dec 31, 2020 | 65.36B | -2.18B | -3.22% |
Dec 31, 2019 | 67.54B | 4.45B | 7.05% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |